Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

Plasma Therapy Dropped From Covid Management Guidelines

May 18, 2021 | Pratirodh Bureau

FILE PHOTO: Medical workers wearing personal protective equipment take care of a patient suffering from the coronavirus disease at a hospital in New Delhi

The Union government on Monday revised the clinical guidance for COVID-19 treatment, dropping the off-label use of convalescent plasma as it was found not beneficial in reducing the progression to severe disease or death.

The development came following a meeting of the ICMR-National Task Force for COVID-19 last week, wherein all members were in favour of removing the use of convalescent plasma from the guidelines citing its ineffectiveness and inappropriate use in several cases.

An Indian Council of Medical Research (ICMR) official said the task force “revised” the Clinical Guidance for Management of Adult COVID-19 Patients and “dropped convalescent plasma (off label)”. The previous guidelines recommended off-label use of plasma therapy at the stage of early moderate disease, that is, within seven days of the onset of symptoms and if there is availability of a high titre donor plasma.

The decision to remove it from the guidelines comes in the backdrop of some clinicians and scientists writing to Principal Scientific Advisor K Vijay Raghavan cautioning against the “irrational and non-scientific use” of convalescent plasma for COVID-19 in the country.

In the letter, which was also marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public health professionals alleged that the current guidelines on plasma therapy are not based on existing evidence and pointed out some very early evidence that indicates a possible association between emergence of variants with lower susceptibility to neutralising antibodies in immunosuppressed people given plasma therapy.

This raises the possibility of more virulent strains developing due to irrational use of plasma therapy which can fuel the pandemic, according to the letter signed by vaccinologist Gagandeep Kang, surgeon Pramesh CS and others.

“We are writing to you as concerned clinicians, public health professionals and scientists from India about the irrational and non-scientific use of convalescent plasma for COVID-19 in the country. This has stemmed from guidelines issued by government agencies, and we request your urgent intervention to address the issue which can prevent harassment of COVID-19 patients, their families, their clinicians and COVID-19 survivors,” said the letter. “The current research evidence unanimously indicates that there is no benefit offered by convalescent plasma for treatment of COVID-19. However, it continues to be prescribed rampantly in hospitals across India,” the letter said.

Tags: COVID-19, ICMR, Indian Council of Medical Research, plasma therapy, Pratirodh

Continue Reading

Previous 10 States Have Over 75% Of India’s Total Active Covid Cases
Next Under Pressure, Biden Works For Ceasefire In Israel-Gaza Violence

More Stories

  • Featured

No Link With Udaipur Killing Accused: Raj BJP Minority Wing

8 hours ago Pratirodh Bureau
  • Featured

Women’s Reproductive Rights In The Shadow Of Roe V. Wade Verdict

13 hours ago Shalini
  • Featured

Floods In Assam Lead To Massive Destruction, Cripple Life

15 hours ago Pratirodh Bureau

Recent Posts

  • No Link With Udaipur Killing Accused: Raj BJP Minority Wing
  • Women’s Reproductive Rights In The Shadow Of Roe V. Wade Verdict
  • Floods In Assam Lead To Massive Destruction, Cripple Life
  • Delhi HC Notice To Police On Zubair’s Plea
  • ‘Why Different Treatment For Farmers & Large Businesses?’
  • Ban On Single-Use Plastic Items Kicks In
  • Improving Road Safety Could Save 30K Lives In India Annually: Study
  • At What Point Is A Disease Deemed To Be A Global Threat?
  • Twitter Accounts Linked To The Farm Movement Withheld: SKM
  • ‘Pandemic Is Changing But It Is Not Over’
  • Chopra Set To Win Medal In Stockholm Event
  • Bonn Climate Talks End In ‘Empty Pages’
  • Civilian Deaths In Russia-Ukraine Conflict Very Disturbing: India
  • Kanhaiya Lal Went To Police Claiming Threat To His Life
  • ‘Journalists Shouldn’t Be Jailed For What They Write, Tweet, Say’
  • ‘Muslims Will Never Allow Taliban Mindset To Surface In India’
  • Recording Mangrove Damage From Cyclones In The Sundarbans
  • Editors’ Guild Condemns Mohd Zubair’s Arrest
  • US SC’s Abortion Verdict Reverses Decades Of Progress: Activists
  • JNUTA, Others Demand Teesta’s Release

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

No Link With Udaipur Killing Accused: Raj BJP Minority Wing

8 hours ago Pratirodh Bureau
  • Featured

Women’s Reproductive Rights In The Shadow Of Roe V. Wade Verdict

13 hours ago Shalini
  • Featured

Floods In Assam Lead To Massive Destruction, Cripple Life

15 hours ago Pratirodh Bureau
  • Featured

Delhi HC Notice To Police On Zubair’s Plea

15 hours ago Pratirodh Bureau
  • Featured

‘Why Different Treatment For Farmers & Large Businesses?’

1 day ago Pratirodh Bureau

Recent Posts

  • No Link With Udaipur Killing Accused: Raj BJP Minority Wing
  • Women’s Reproductive Rights In The Shadow Of Roe V. Wade Verdict
  • Floods In Assam Lead To Massive Destruction, Cripple Life
  • Delhi HC Notice To Police On Zubair’s Plea
  • ‘Why Different Treatment For Farmers & Large Businesses?’
Copyright © All rights reserved. | CoverNews by AF themes.